Market Research Logo

MediPoint: Total Knee Replacement - North America Analysis and Market Forecasts

MediPoint: Total Knee Replacement - North America Analysis and Market Forecasts

Summary

North American Total Knee Replacement (TKR) market was estimated at US$3.63B in 2016 across the three markets covered in this report (Canada, Mexico, and the US). By the end of the forecast period in 2023, it is estimated that the market will grow to approximately US$4.23B at a Compound Annual Growth Rate (CAGR) of 2.2%.

The US represented the largest portion of the market in 2016, holding more than 94% of the regional revenue, and is expected to maintain this dominance through the forecast period albeit with a 2.1% CAGR, the lowest in the region. Mexico is expected to be the fastest-growing market through 2023, at a CAGR of 4.3%.

Total Knee Replacement (TKR) is a viable treatment option for patients whose knees have become excessively worn or degenerated due to osteoarthritis. The direct costs of nonsurgical management (including medication and physical therapy) of knee osteoarthritis, one of the most common joint injuries, pale in comparison to the indirect costs such as loss of earnings, disability payments, and reduced productivity.

Key drivers of the TKR market in the forecast period are -

  • Growing prevalence of osteoarthritis (OA) due to the pandemic of aging and obesity.
  • Continued technological advancements in joint reconstruction surgeries, such as computer-assisted navigation systems and robotic technologies, which keep pushing the frontier of the market.
  • Major underserved population for joint replacement in late-stage arthritis in the emerging markets, driving procedural numbers up for the knee replacement market.
  • Healthcare reform and a focus on economical and sustainable modes of treatment.
  • Commoditization of implant solutions.
After the 2015 megamerger of Zimmer and Biomet, today’s competitive landscape in the global knee reconstruction market is relatively stable, with Zimmer Biomet, the clear leader, representing almost a third of the market. DePuy Synthes, Stryker, and Smith & Nephew are also key competitors in the field, together accounting for about half of total revenues in the sector. The remainder of the market is occupied by several small- to mid-cap orthopedic companies, with MicroPort and Exactech leading the pack. Medtronic recently entered the primary knee arthroplasty market with its purchase of Responsive Orthopedic Knee System.

The report MediPoint: Total Knee Replacement - North America Analysis and Market Forecasts, focuses on the market outlook for Total Knee Replacement (TKR) devices in North America (Canada, Mexico, and US). The analysis identifies the key unmet needs in the Total Knee Replacement (TKR) market, discusses the major drivers and barriers of adoption, and provides an in-depth understanding of physicians’ perceptions and the future outlook for this market by segment and geography.

In depth, this report provides the following -
  • Overview of recent key industry events and analysis of their market impact.
  • Annualized total market revenue, procedure trends, and market outlooks by segment and by region through 2023.
  • Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.
  • Analysis of the current and future market competition in the global Total Knee Replacement (TKR) market. Insightful review of industry drivers, barriers, and challenges.
Companies mentioned in this report: esculap, DePuy Synthes, Exactech, Lima Corporate, Medacta, Medtronic, MicroPort Orthopedics, Smith & Nephew, Stryker, Waldemar Link, Zimmer Biomet.

Scope
  • Overview of recent key industry events and analysis of their market impact.
  • Annualized total market revenue, procedure trends, and market outlooks by segment and by region through 2023.
  • Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.
  • Analysis of the current and future market competition in the global TKR market. Insightful review of industry drivers, barriers, and challenges.
Reasons to buy

The report will enable you to -
  • Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.
  • Develop business strategies by understanding the trends shaping and driving the video laparoscopes market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the video laparoscopes market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in country-specific video laparoscopes market from 2014-2023.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.


1 About the Authors
1.1 Analyst
1.1.1 Tobe Madu, MSc, Analyst, Medical Devices
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Executive Summary
3.1 Key Metrics
3.2 Market Dynamics
3.3 Key Players
3.4 Future Outlook
3.5 What Do Physicians Think?
4 Introduction
4.1 Catalyst
4.2 Related Reports
4.3 Upcoming Related Reports
5 Market Outlook
5.1 Procedure Trends
5.2 Pricing Trends
5.3 Revenue Trends
5.4 Company Share Analysis
6 Market Insights
6.1 North America
6.1.1 Canada
6.1.2 Mexico
6.1.3 US
7 Competitive Assessment
7.1 Overview
7.1.1 Computer Navigation Technologies
7.1.2 Robotic Technologies
7.1.3 Generic Implants to Address Cost Concerns
7.1.4 Advanced Materials
7.1.5 Emerging Countries
7.1.6 Augmented implants
7.2 Aesculap
7.2.1 Portfolio Assessment
7.2.2 Competitive Positioning
7.3 DePuy Synthes
7.3.1 Portfolio Assessment
7.3.2 Deal Analysis
7.3.3 Competitive Positioning
7.4 Exactech
7.4.1 Portfolio Assessment
7.4.2 Competitive Positioning
7.5 Lima Corporate
7.5.1 Portfolio Assessment
7.5.2 Deal Analysis
7.5.3 Competitive Positioning
7.6 Medacta
7.6.1 Portfolio Assessment
7.6.2 Competitive Positioning
7.7 Medtronic
7.7.1 Portfolio Assessment
7.7.2 Deal Analysis
7.7.3 Competitive Positioning
7.8 MicroPort Orthopedics
7.8.1 Portfolio Assessment
7.8.2 Competitive Positioning
7.9 Smith & Nephew
7.9.1 Portfolio Assessment
7.9.2 Deal Analysis
7.9.3 Competitive Positioning
7.10 Stryker
7.10.1 Portfolio Assessment
7.10.2 Deal Analysis
7.10.3 Competitive Positioning
7.11 Waldemar Link
7.11.1 Portfolio Assessment
7.11.2 Competitive Positioning
7.12 Zimmer Biomet
7.12.1 Portfolio Assessment
7.12.2 Deal Analysis
7.12.3 Competitive Positioning
7.13 Other Players
8 Appendix
8.1 Bibliography
8.2 Abbreviations
8.3 Methodology
8.3.1 Overview
8.3.2 Coverage
8.3.3 Secondary Research
8.3.4 Forecasting Methodology
8.3.5 Primary Research Summary
8.4 About MediPoint
8.5 About GlobalData
8.6 Contact Us
8.7 Disclaimer
List of Tables
Table 1: TKR Market, Key Metrics, 2016-2023
Table 2: North America TKR Procedure Volume Forecast, 2014-2023
Table 3: North America TKR Implant Average Selling Price ($) Forecast, 2014-2023
Table 4: North America TKR Market Revenue Forecast ($M), 2014-2023
Table 5: North America TKR Company Share Analysis, 20161
Table 6: Aesculap - Key Marketed Products Assessment
Table 7: Aesculap - Key Clinical Trials
Table 8: DePuy Synthes - Key Marketed Products Assessment
Table 9: DePuy Synthes - Key Clinical Trials
Table 10: Exactech - Key Marketed Products Assessment
Table 11: Exactech - Key Clinical Trials
Table 12: Lima Corporate - Key Marketed Products Assessment
Table 13: Lima Corporate - Key Clinical Trials
Table 14: Medacta - Key Marketed Products Assessment
Table 15: Medacta - Key Clinical Trials
Table 16: Medtronic - Key Marketed Products Assessment
Table 17: MicroPort - Key Marketed Products Assessment
Table 18: Microport - Key Clinical Trials
Table 19: Smith & Nephew - Key Marketed Products Assessment
Table 20: Smith & Nephew - Key Clinical Trials
Table 21: Stryker - Key Marketed Products Assessment
Table 22: Stryker - Key Clinical Trials
Table 23: Waldemar Link - Key Marketed Products Assessment
Table 24: Waldemar Link - Key Clinical Trials
Table 25: Zimmer Biomet - Key Marketed Products Assessment
Table 26: Zimmer Biomet - Key Clinical Trials
Table 27: Summary of Other Players in the TKR Market, 2016
List of Figures
Figure 1: North America TKR Market Share Comparison by Country, 2016 and 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report